Aurobindo Pharma experienced an increase of 1.14%, reaching Rs 1,113.55, following the establishment of a new wholly owned subsidiary in Chile, named Eugia Pharma Chile SpA, by its wholly owned step-down subsidiary, Eugia Pharma B.V.
Superhealth, the first hospital network in India to offer zero wait times and zero commissions, has today announced a significant strategic partnership with the global imaging innovator, United Imaging Healthcare
Novo Nordisk's primary investor has taken steps to gain control of the pharmaceutical company's board, pledging to concentrate more on the crucial U.S. market in order to rejuvenate sales of the highly successful weight-loss medication Wegovy, follow
Iberia Pharmaceuticals, a leading name in skincare, has launched KeyCi, a science-backed skincare brand designed for modern consumers aged 18–45. KeyCi offers high-performance, dermatologically tested products that are vegan, cruelty-free...
Strides Pharma Science Limited today announced that one of its step-down wholly owned subsidiary will market the world’s first WHO-prequalified generic version of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Africa, strengthening...
BASF has introduced Lutavit A/D3 1000/200 NXT, an advanced vitamin formulation that integrates vitamins A and D3 into one microencapsulated product. Representing BASF’s reentry into the market, this new solution offers enhanced efficiency, ease of us
Aragen, a prominent global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Neeraj Garg as Chief Executive Officer of its Discovery Solutions division
Eli Lilly and Company has reported positive topline results from its Phase 3 ACHIEVE-2 and ACHIEVE-5 clinical trials evaluating orforglipron in adults with type 2 diabetes
The pharmaceutical market is under growing pres¬sure as governments all over the world tighten reg¬ulation and enforcement. The presence of frequent quality audits and non-conformance citations is a serious threat and usually leads to operational hal
Rehan Khan, Managing Director of MSD India, shares that India has more unicorn startups than billion-dollar drugs. Despite a huge patient pool with diabetes, hypertension, and cancer, the country has yet to deliver a homegrown therapy crossing $1 bil
.jpg)
, CDSCO.jpg)